Emergency Department Discharge for Type II Supracondylar Fractures - PROSPR Phase 5

Launched by THE HOSPITAL FOR SICK CHILDREN · Nov 20, 2023

Keywords

ClinConnect Summary

The clinical trial titled "Emergency Department Discharge for Type II Supracondylar Fractures - PROSPR Phase 5" is studying whether children with a specific type of arm fracture, called Type II supracondylar fractures, can safely go home from the Emergency Department (ED) in a temporary cast. The idea is that these children can manage their pain without using opioids, both before and after they have surgery to fix the fracture. The researchers believe that if this approach works, it will help free up hospital beds for other patients without affecting the quality of care for the children.

This trial is open to children who need surgery for a Type II supracondylar fracture, and there are no specific exclusions for participation. If eligible, participants can expect to be sent home with guidance on how to manage their pain and care for their injury until their surgery. The study is not yet recruiting, but it aims to improve care while making the best use of healthcare resources.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • requiring surgery for Type II supracondylar fracture
• Exclusion Criteria:
• • none